Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wansbrough-Jones

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
AIDS (London, England)|December 31, 1997
Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patientA Weir, M Wansbrough-Jones
Journal of the Royal Society of Medicine|November 17, 1998
Pneumococcal endocarditis, pneumonia and meningitis complicated by necrosis of a limbA Weir, D Lam, M Wansbrough-Jones
The British Journal of Radiology|November 1, 1992
Dense bonesS Vinnicombe, C Heron, M Wansbrough-Jones
The Journal of Infection|March 1, 1994
Papulonecrotic tuberculide and erythema induratum as presenting manifestations of tuberculosisD Roblin, R Kelly, M Wansbrough-Jones, et al.
Journal of Immunological Methods|January 1, 1977
Temperature dependence of antigen-specific rosette formation by lymphocytes from immunised miceM Wansbrough-Jones, D Mirjah, M Druguet, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxidesR Phillips, O Adjei, S Lucas, et al.
Lancet (London, England)|August 22, 1992
Effect of type of haematology analyser on CD4 countG Robinson, L Morgan, M Evans, et al.
Clinical and Vaccine Immunology : CVI|November 14, 2008
Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humansF S Sarfo, R O Phillips, E Ampadu, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
In vitro killing of Mycobacterium ulcerans by acidified nitriteR Phillips, S Kuijper, N Benjamin, et al.
Antimicrobial Agents and Chemotherapy|June 23, 2010
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans diseaseFred Stephen Sarfo, Richard Phillips, Kingsley Asiedu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
AIDS (London, England)|December 31, 1997
Mucosal Kaposi's sarcoma following protease inhibitor therapy in an HIV-infected patientA Weir, M Wansbrough-Jones
Journal of the Royal Society of Medicine|November 17, 1998
Pneumococcal endocarditis, pneumonia and meningitis complicated by necrosis of a limbA Weir, D Lam, M Wansbrough-Jones
The British Journal of Radiology|November 1, 1992
Dense bonesS Vinnicombe, C Heron, M Wansbrough-Jones
The Journal of Infection|March 1, 1994
Papulonecrotic tuberculide and erythema induratum as presenting manifestations of tuberculosisD Roblin, R Kelly, M Wansbrough-Jones, et al.
Journal of Immunological Methods|January 1, 1977
Temperature dependence of antigen-specific rosette formation by lymphocytes from immunised miceM Wansbrough-Jones, D Mirjah, M Druguet, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxidesR Phillips, O Adjei, S Lucas, et al.
Lancet (London, England)|August 22, 1992
Effect of type of haematology analyser on CD4 countG Robinson, L Morgan, M Evans, et al.
Clinical and Vaccine Immunology : CVI|November 14, 2008
Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humansF S Sarfo, R O Phillips, E Ampadu, et al.
Antimicrobial Agents and Chemotherapy|July 27, 2004
In vitro killing of Mycobacterium ulcerans by acidified nitriteR Phillips, S Kuijper, N Benjamin, et al.
Antimicrobial Agents and Chemotherapy|June 23, 2010
Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans diseaseFred Stephen Sarfo, Richard Phillips, Kingsley Asiedu, et al.
Pageof 2